Digitized 50% of Pre-Registration process: With Certinal’s digital forms and streamlined processes, 50% of patient pre-registrations are now completed digitally, significantly reducing reliance on ...

NHS managers will be sacked if they fail to improve patient care and struggling hospitals will be named and shamed as part of ...

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

UT Health San Antonio’s new $472 million Multispecialty and Research Hospital is envisioned as “a place of firsts,” a symbol of “hope for the hopeless” that will expand the reach of the growing, ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...

Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical ...

A group of nurses has urged MPs to embrace a “historic opportunity” to change the law on assisted dying, but opposition ...

Cash Position: Cash, cash equivalents, and marketable securities were $463.3 million as of September 30, 2024, compared to $322.0 million as of December 31, 2023. Erasca expects its current cash, cash ...

Detailed price information for Seres Therapeutics Inc (MCRB-Q) from The Globe and Mail including charting and trades.

AHMEDABAD: Following the deaths of two patients at Ahmedabad's controversial Khyati Hospital, the Gujarat government has ...

Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.